A closer look at “New Framework Aims to Predict Antibiotic Resistance Early in Drug Development”, exactly as the source publishes it. Researchers at the HUN-REN Biological Research Centre in Szeged and the Hungarian Centre of Excellence for Molecular Medicine have proposed a five-step framework to predict antibiotic resistance risks early in drug development. Published in Nature Reviews Microbiology, the approach could help refine drug candidates, reduce costly failures, and preserve the effectiveness of new antibiotics. The framework integrates evolutionary principles, genomics, and clinical data to identify resistance liabilities before drugs reach patients.
By anticipating how bacteria might evolve resistance, developers can modify compounds or adjust dosing strategies. This matters because antibiotic resistance is a growing global health threat, and many promising drugs fail late in development due to unforeseen resistance. The Szeged team's method offers a proactive way to safeguard new therapies, potentially saving years and millions of dollars while ensuring that effective antibiotics remain available for future generations. This listing links straight to the original page, where the content is available in full.